Industry P pharmaphorum
AZ seeking $1.5bn in annual savings by end-2029
AZ seeking $1.5bn in annual savings by end-2029 Phil.Taylor Fri, 30/10/2026 - 09:06
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Industry P pharmaphorum
AZ seeking $1.5bn in annual savings by end-2029 Phil.Taylor Fri, 30/10/2026 - 09:06
Industry
Labiotech
In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move from cancer into diabetes. The post Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3) appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Un…
Industry B BioTechniques
Original story from Delft University of Technology (The Netherlands). Scientists have created a soft robot arm capable of grabbing and moving objects, powered, believe it or not, by algae and light. Tiny underwater algae sway gently in the current. All of a sudden, a light…
Industry P Pharmafile
Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for patients who may benefit from cardiac resynchronisation therapy (CRT) but in whom effective treatment using conventional biventricular pacing cannot be achieved.…
Industry E EMBL
A combination of cryogenic light and electron tomography visualises ribosome assembly pathways inside intact human cells, providing subnanometer-resolution pre-ribosome structures, while also revealing new configurations.
Industry
European Biotechnology
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: two CEO transitions, three medical appointments and a finance hire at a young French biotech. The post Orbis and Al…
Industry P pharmaphorum
Navigating geopolitical risks: Practical and legal mitigations for the pharmaceutical industry Nicole.Raleigh Fri, 30/10/2026 - 06:58
Research S Science News
NIH’s arguments opposing the union don’t hold up, ruled a federal entity that oversees labor relations
Industry S Science News
Exercise triggers bone cells called osteocytes to secrete antiaging chemicals in mice
Funding
BioPharma Dive
The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.
Industry F FDA Law Blog
By Andrew J. Hull & Karla L. Palmer —
Funding
BioCentury
BIOCENTURY | FINANCEJUVIA, LIGHTSPEED LEAD DREN’S $350M ROUND AS ONCOLOGY PROGRAM ADVANCES: VENTURE REPORTPlus: Formation Bio’s $600M accelerator fund; Flagship assembles three portfolio companies’ tech into Etcelera; and more
Industry N Nature Medicine
Industry N Nature Biomedical Engineering
Clinical
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTESMO’S FIRST-IN-HUMAN TRIALS: ADCS LEAD, BUT PAYLOAD INNOVATION LAGSBioCentury’s analysis of first-in-human trials at ESMO 2026 highlights target innovation among translational ADC programs
Funding
BioCentury
BIOCENTURY | DATA BYTETALLYING EQUITY IN NEWCO DEALS AS COINS RAISES THE STAKESRecent dealmaking shows how widely Treasury’s proposed COINS restrictions could reverberate across the NewCo model
Research
Inside Precision Medicine
Two major studies have identified the most accurate non-invasive tests for diagnosing and assessing the severity of metabolic dysfunction-associated steatotic liver disease (MASLD), potentially reducing the need for liver biopsies. The post Most Accurate Non-Invasive Tests for Li…
Software A Arcadia Science
We added a helix penalty that shifted ESMFold2 binder designs toward β-sheets across five targets. The shift began early in optimization and increased the number passing a sheet-content and confidence screen, despite lower average confidence.
Industry
BioCentury
BIOCENTURY | DATA BYTECO-CO DEALS MAY BE ONE CASUALTY OF THE COINS ACT FOR U.S. BIOTECHSProposed restrictions could curb U.S. participation in China co-development deals, where European buyers are already ahead
Agriculture
CropLife
Flakne has been named inaugural recipient of NASDA's Bill Northey Legacy Award and also received CropLife America's Lea S. Hitchner Award. The post Dave Flakne of Syngenta Honored with Two Prestigious Agriculture Leadership Awards appeared first on CropLife.
Industry
Bio.News
The most dangerous antimicrobial-resistant (AMR) pathogens in America are causing an estimated 9.7 million infections and 50,800 deaths in the U.S. each year, says […] The post CDC report details impact of AMR pathogens appeared first on Bio.News.
Industry
BioPharma Dive
Starting in 2027, the controversial drug middlemen will have to share a broad swath of fee and compensation data with self-funded employer clients. Employers cheered the rule, while PBMs slammed it as government overreach.
Agriculture
CropLife
The new technologies help growers improve nutrient efficiency, strengthen crop resilience, and unlock greater productivity from every acre. The post YaraAmplix PROCOTE OPTIMIZE and OPTITRAC Biostimulants Now Commercially Available in the U.S. appeared first on CropLife.
Software C Chan Zuckerberg Biohub
A technology built by Biohub scientists uses artificial intelligence to recognize sepsis from images of millions of blood cells, without being told what to look for. The post Sepsis is linked to 11 million deaths a year. A new machine-learning platform could help catch it within…
Industry
MedCity News
BioMarin gains rights to a Fabry disease enzyme replacement therapy with potential dosing advantages over products from Sanofi and Chiesi Group. BioMarin’s new clinical-stage asset could reach patients ineligible for the Fabry drug that came with its Amicus Therapeutics acquisiti…
Industry
GEN
In developing fetuses, the human brain generates an excess of neurons, most of which are eliminated around when the baby is born. New research suggests that this is an important quality-control mechanism. The post Brain Quality Control Selectively Eliminates Neurons with Abnormal…
Industry
C&EN Pharmaceuticals
The venture firm has combined 3 platforms into 1
Manufacturing B BioPharm International
In the final part of a three-part interview, Anurag Rathore, PhD, professor of chemical engineering at IIT Delhi, explains how his team has cut monoclonal antibody costs toward $10 per gram and why process intensification will spread one unit operation at a time.
Industry P Pharmaceutical Commerce
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years beginning on or after July 1, 2027.
Regulatory
Bio.News
BIO praised a Food and Drug Administration (FDA) initiative targeting more tailored, patient-centered, and predictable development of rare disease drugs, while recommending ways to […] The post BIO supports FDA’s new Fit-for-Purpose Rare Disease Framework Initiative appeared firs…
Software D Diamond Age Data Science
This blog post contains contributions from Dale Bodian and Jason Warner. The most expensive AI mistakes usually come from forcing complex methods onto datasets that aren’t ready for them. In the first part of our ‘AI in the Wild’ series, we talked about these mistakes and the imp…
Industry
GEN
Researchers created the first comprehensive whole-body single-cell atlas of an adult vertebrate, the tiny, transparent fish Danionella cerebrum, offering a new resource for studying brain regeneration, cellular diversity, and investigating how different tissues function together.…
Industry
Bio.News
The United States leads the world in biotech innovation, and a major driver is its strong intellectual property (IP) system. In fact, IP rights […] The post IP: American as apple pie and essential for biotech appeared first on Bio.News.
Industry
Inside Precision Medicine
Population-scale transcriptomics and chromatin accessibility profiling uncover thousands of disease-associated regulatory signals missed by transcriptomic analyses, raising questions about how many therapeutic targets are unknown. The post Single-Nucleus Multi-Omic Profiling Reve…
Industry
Inside Precision Medicine
Switching low-fat diet for just a few days at the onset of an inflammatory disease such as psoriasis could impact its trajectory in both the short and long term, according to a preclinical study. The post Short-Term Low-Fat Diet Has Lasting Inflammatory Disease Benefits appeared…
Industry P pharmaphorum
Flagship joins three biotechs together to form Etcelera Phil.Taylor Thu, 29/10/2026 - 17:12
Industry B BioPharm International
As part of BioPharm International’s AAPS PharmSci 360 2026 coverage, Nanoform’s Chris Worrall explains why stability and viscosity have kept antibody formulations below 200 mg/mL, and how a low-temperature particle engineering process and non-aqueous suspensions could support ult…
Industry B BioPharm International
In the second part of an interview for BioPharm International’s AAPS PharmSci 360 2026 coverage, Nanoform’s Chris Worrall shares 18-month stability data for a 414 mg/mL trastuzumab suspension and explains how ultra-high-concentration formulations could shorten administration and…
Industry
Inside Precision Medicine
Understanding the cause of the outbreak on a population level can help with public health response to prevent further outbreaks in Canada and around the globe. The post Lessons Learned from Canadian Measles Outbreak appeared first on Inside Precision Medicine.
Software
Fierce Pharma
How AI turns field conversations into actionable insights dwunderlin Thu, 10/29/2026 - 12:39